Equity Overview
Price & Market Data
Price: $0.889
Daily Change: $0.00 / 0.00%
Daily Range: $0.83 - $1.20
Market Cap: $22,489,358
Daily Volume: 129,019
Performance Metrics
1 Week: -11.12%
1 Month: -18.46%
3 Months: -19.20%
6 Months: 11.10%
1 Year: 64.32%
YTD: -19.20%
Company Details
Employees: 5
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.